Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - MEDTOX SCIENTIFIC INC | Financial_Report.xls |
| 10-K - 10-K - MEDTOX SCIENTIFIC INC | file10-k.htm |
| EX-23 - EXHIBIT 23 - MEDTOX SCIENTIFIC INC | ex23.htm |
| EX-31.1 - EXHIBIT 31.1 - MEDTOX SCIENTIFIC INC | ex31-1.htm |
| EX-21.1 - EXHIBIT 21.1 - MEDTOX SCIENTIFIC INC | ex21-1.htm |
| EX-32.1 - EXHIBIT 32.1 - MEDTOX SCIENTIFIC INC | ex32-1.htm |
| EX-31.2 - EXHIBIT 31.2 - MEDTOX SCIENTIFIC INC | ex31-2.htm |
| EX-10.35 - EXHIBIT 10.35 - MEDTOX SCIENTIFIC INC | ex10-35.htm |
EXHIBIT 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of MEDTOX Scientific, Inc. (the “Company”) on Form 10-K for the year ended December 31, 2011, as filed with the Securities and Exchange Commission (the “Report”), I, Kevin J. Wiersma, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that:
(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
Dated: March 8, 2012
|
By: /s/ Kevin J. Wiersma
|
|
Kevin J. Wiersma
Chief Financial Officer
|